Introduction
Breast cancer incidence in India has been increasing steadily in the last 30 years, and currently, it is the most common cancer among Indian women, with age-adjusted incidence rate of 25.8/100,000 women. [1, 2] Younger women (≤40 years) constitute about 11%-31% of all breast cancer cases in India. [3] [4] [5] Further, recent data suggest a trend of increasing rates of breast cancer in younger women with annual percentage change (APC) ranging from 1% to 4.24% in 15-34 years' age group, as compared to APC of 0.37%-2.97% in 35-44 years' age group and 0.53%-2.64% in patients >64 years. [6, 7] Higher rates of breast cancer in younger women have also been reported from other South Asian countries. [8, 9] A number of risk factors have been identified for breast cancer, such as early age of menarche, late menopause, nulliparity, delayed first child birth, reduced duration of breastfeeding, use of oral contraceptives and hormone replacement therapy, family history of breast/ovarian cancer, history of previous breast biopsy, increased body mass index (BMI), and consumption of animal products, alcohol, etc. [2, 5, 10] However, these factors do not address a considerable portion of the risk, especially in women who are young. Besides, in Indian women, the risk factor profile is different from their Western counterparts, as early first childbirth, multiparity, and breastfeeding are social norms and the use of oral contraceptives and hormone replacement therapy is low. [5, 10, 11] Inherited/familial breast cancer accounts for 5%-10% of cases. [2, 5, 11] Rising rate of breast cancer in India is being attributed to westernization of lifestyles. Yet, the Western population themselves who have the same risk factors do not have onset at younger ages. Hence, there might be a role of environmental factors, which is yet to be explored.
Environmental pollution due to the use of pesticides has been reported to play a role in increasing the risk for various cancers. [12] Among these, the role of estrogenic-organochlorine (OC) compound pesticide has been evaluated for their potential role as a risk factor for breast cancer. [13] A number How to cite this article: Kaur N, Swain SK, Banerjee BD, Sharma T, Krishnalata T. Organochlorine pesticide exposure as a risk factor for breast cancer in young Indian women: A case-control study. South Asian J Cancer 2019;8:212-4.
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Breast Cancers ORIGINAL ARTICLE used to evaluate the significance of difference between the two groups as appropriate. Mann-Whitney U-test was used to test the significance of association of serum levels of OC compound with breast cancer. Odds ratio for various risk factors was calculated by using univariate logistic regression analysis.
Results

Demographic and clinical characteristics of the study population
The mean age of breast cancer patients and control group was 35.79 years and 36.31 years, respectively. The most common stage of presentation was Stage II (36%), followed by locally advanced breast cancer (Stage III, 31%) and advanced metastasis disease (10%). The most common histological type was invasive ductal carcinoma (78.6%) and 37.5% had histological Grade-2 disease. In our study, 60% of patients were estrogen receptor +ve, 34.3% were progesterone receptor +ve, and 28.57% had triple-negative receptor status.
Risk factor profile of the study population
The prevalence of various known risk factors in breast cancer patients was very low. None of the patients were nullipara. The mean age at first child birth was 20.5 ± 3 years, and the average duration of breastfeeding was 5.80 ± 4.04 years. Only one patient had a strong family history of breast cancer and two had a history of biopsy for benign breast disease. Almost 80% were vegetarian, and none reported prolonged use of oral contraceptives. However, a statistically significant difference was noted in the age of menarche between the cases (12 ± 1 years) and controls (13 ± 1 years) (P = 0.002) and also in BMI between the two groups (cases [25.08 ± 2.98], controls [23.06 ± 2.64] [P = 0.001]).
Organochlorine pesticide exposure in the study population
Analysis of the serum levels of various isomers and metabolites of OC pesticides showed that the α-, β-, γ-HCH; heptachlor; DDE; endosulfan-1 and endosulfan-2; and dieldrin isomer levels were significantly higher in patients with carcinoma breast than controls [ Table 1 ]. On further analysis, odds ratios were found to be significant for β-HCH, heptachlor, dieldrin, and p, p' DDE, at 4.15, 3.14, 11.74, and 8.81, respectively [ Table 2 ].
Discussion
OC pesticides (OCPs) are synthetic pesticides widely used worldwide. They belong to the group of chlorinated hydrocarbon derivatives, which have vast application in the chemical industry and agriculture. These compounds are known for their high toxicity, slow degradation, and bioaccumulation. Even though many of the compounds were banned in developed countries in the 1970s, insecticides such as DDT, HCH, aldrin, and dieldrin are still under use in developing countries of Asia. [20] The most commonly used pesticide in agricultural practice is DDT, which is moderately hazardous, with high persistence and a half-life of 2-15 years. OCPs can enter the environment after pesticide applications, polluted waste discarded into landfills, and discharges from industrial units that synthesize these chemicals. Food items such as meat, fish, poultry, and dairy products serve as the main sources of exposure to these pesticides through diet. [21] These pesticides cause neurological damage and endocrine disorders and are reported to increase the risk of hormone-related cancers including breast, prostate, stomach, and lung cancers. [12, 14] Further, individuals with lower age group are reported to have higher risk of health hazards due to pesticides than those in higher age group. [19] The present study found a statistically significant association between exposure to OC pesticides and risk of carcinoma breast in young women. Significantly higher blood levels of α-, β-, γ-HCH; heptachlor; DDE; endosulfan-1; dieldrin; and endosulfan-2 were found in breast cancer patients. However the odds ratio for breast cancer were found significant only with β-HCH, heptachlor, DDE, and dieldrin. These results are consistent with many other reports, mostly from countries where exposure to OCPs continues till date. [22] [23] [24] Høyer et al. in their study in Danish population reported that women with increased level of serum dieldrin had an increased risk of breast cancer. [25] Arrebola et al. from Tunisia reported that β-HCH, heptachlor, hexachlorobenzene, and p, p' DDE were positively associated with breast cancer risk. [26] However, many case-control studies published from Europe, Canada, and North America failed to find any significant association. [16, 17, 27] This is probably because exposure to OCPs is low in these populations overall, and hence can not be a significant contributor to breast cancer risk. Based on an exhaustive review of epidemiological and laboratory studies, Grey JM et al. (2017) in their report concluded that an overall comparison of the association between disease risk and DDT use in developed countries (where DDT has been banned for several decades) and in developing countries (where DDT use is still prevalent) supports the premise that exposures to DDT are associated with an increased risk of breast cancer. [13] 
Conclusions
Exposure to OCPs could be contributing to an increasing incidence of breast cancer in younger women in India.
Limitation
The sample size in this study is small and hence underpowered to ascertain clinical significance of these findings.
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